Under both Drake’s and Lynch’s versions, the expense of deleterious mutations is exactly what drives mutation premiums down (Drake 1991; Lynch 2010; Sung et al. 2012). consequently, under each styles, an increase in the typical expense of mutations would produce a minimize in mutation prices. To examine this, Drake examined mutation costs of th